Merck, Dr. Reddy’s in biosimilars deal – Livemint.com

In contrast to conventional chemical medicines, biotech products are impossible to copy precisely, forcing generic companies to develop biosimilars, which are close to the original but need to be sold as separate medicines. Merck is at risk from cheaper …